Latest News and Press Releases
Want to stay updated on the latest news?
-
Novadip Biosciences Reports Positive Interim Analysis of Phase I/II Bone Non-Union Study with NVD003
Novadip Biosciences Reports Positive Interim Analysis of Phase I/II Bone Non-Union Study with NVD003 Bone healing demonstrated at six-months after treatment with favorable safety profileNVD003 is...
-
Novadip Biosciences Reports Positive Interim Analysis of Phase I/II Bone Non-Union Study with NVD003
Novadip Biosciences Reports Positive Interim Analysis of Phase I/II Bone Non-Union Study with NVD003 Bone healing demonstrated at six-months after treatment with favorable safety profileNVD003 is...
-
Novadip Biosciences to present data at 17th Annual Meeting of the International Federation for Adipose Therapeutics and Science Mont-Saint Guibert, Belgium, 4 December, 2019: Novadip Biosciences...
-
Novadip Biosciences Presents Clinical Case Study on Next Generation Tissue Regeneration Therapy for Critical Size Bone Reconstruction at EORS Conference Study highlights potential...
-
Novadip Biosciences presents poster at 11th annual The Bioprocessing Summit Presentation to focus on manufacturing platform for tissue engineering Mont-Saint Guibert, Belgium, 12 August 2019:...
-
Novadip Biosciences presents data at 30th annual EURAPS Research Council Meeting Data demonstrates safety and efficacy of allogenic 3D scaffold-free tissue engineered product for deep thickness...
-
Novadip Biosciences to present at 20th annual Bio€quity Europe Conference Belgium, 16 May 2019: Novadip Biosciences (“Novadip”), a regenerative medicine company and pioneer in the development of...